# Cranberry fruit powder × six-month IPSS reduction Verdict 2986 · Evidence Check Stored-material review date: Not recorded Original evidence cut-off: 2026-09-07 Review-criteria version: 1.0 Public page/material preparation date: 2026-10-16 Clinical papers were not read directly; existing review summaries were checked. No new clinical-literature search was performed. Unverified does not mean that research is absent or that there is no effect. ## Assessment scope - Population: The Korean text records124 men aged45 or older with IPSS at least8; the English text says aged over45. Group allocation, completion, analysis, attrition and baseline IPSS are unverified. - Ingredient, formulation and route: Three groups received Flowens™ branded cranberry fruit powder250mg/day,500mg/day or placebo. Composition, PAC content, actual adherence and supply details are unverified. - Dose: 250/500mg/day and six months are research-exposure records. Recommended intake, juice or PAC conversions, and preventive or treatment doses are not created. - Comparator: Double-blind placebo control. Placebo composition, sensory matching, exposure, concurrent care and masking-maintenance details are unverified. - Measured outcome: Distinguish six-month group IPSS changes of−3.1/−4.1/−1.5 points, the text’s approximate placebo differences of−1.6/−2.6 points, and comparison P values of approximately .05 for250mg and <.001 for500mg. Exact adjusted effects, CIs and denominators are unverified. Objective-flow/residual-urine changes from baseline in the500mg group are separate. - Duration: Endpoint labels include three and six months; current quantitative values concern six months. Three-month values/denominators, exact objective-outcome times, post-trial persistence and long-term clinical outcomes are not linked. - Questions outside this scope: Mixing group-specific changes with historical approximate placebo differences, or creating new effects, CIs or arithmetic; Arbitrarily harmonizing the text’s MID3.1–5.2 with supporting-citation values5.2 overall/3.2 moderate, or inferring no effect for every individual; Transferring values, units or timing across total IPSS, subscores, QoL, objective flow, residual urine, prostate size, or three/six months; Treating the Flowens test product and250/500mg research exposure as equivalent to juice, other PAC products or recommended intake; Adding the same124 participants, groups, times, two sheets and observational MID cohort as independent efficacy trials or participant totals; Inheriting parent C46, axes or historical checks as subclaim scores/current review, or creating intake, urinary/prostate-treatment, preventive or replacement advice ## Checklist items ### N01 · Selected IPSS question and original grade Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The existing question is ‘Reduction in six-month IPSS’, graded C; the note says it was statistically favorable but small versus placebo. Subclaim score, status and axes are absent and are not filled with parent C46. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Separate subclaim score, status and axes are absent from the original record. - Required materials and conditions: Selected wording, note, grade and parent verdict - Materials to obtain first: Separate subclaim score, status and axes are absent from the original record. - Further research: Material needed: Separate subclaim score, status and axes are absent from the original record. This records needed materials; no new research was executed. - Conditions for verification: Material for Selected wording, note, grade and parent verdict must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Selected wording, note, grade and parent verdict with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N02 · Participants, symptoms and age criteria Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The Korean text records 124 men aged45 or older with IPSS at least8; the English text says aged over45. The age expressions are not arbitrarily harmonized or extended to all men or diagnosed prostate disease. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact age range, baseline IPSS distribution, diagnoses, history and group allocation counts are unverified. - Required materials and conditions: Eligibility, baseline IPSS, age and group denominators - Materials to obtain first: Exact age range, baseline IPSS distribution, diagnoses, history and group allocation counts are unverified. - Further research: Material needed: Exact age range, baseline IPSS distribution, diagnoses, history and group allocation counts are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Eligibility, baseline IPSS, age and group denominators must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Eligibility, baseline IPSS, age and group denominators with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N03 · Identity of the branded cranberry powder Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The test product was branded cranberry fruit powder, identified as Flowens™ in the citation. Ordinary cranberry, juice and products with different PAC content are not treated as the same intervention. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Test-product composition, PAC content, manufacturing, standardization, batches and correspondence to ordinary products are unverified. - Required materials and conditions: Product, manufacturing, composition, form and test-product records - Materials to obtain first: Test-product composition, PAC content, manufacturing, standardization, batches and correspondence to ordinary products are unverified. - Further research: Material needed: Test-product composition, PAC content, manufacturing, standardization, batches and correspondence to ordinary products are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Product, manufacturing, composition, form and test-product records must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Product, manufacturing, composition, form and test-product records with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N04 · Research exposure at250 and500mg Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: This was a six-month study of250mg/day,500mg/day and placebo. These are study conditions; personal intake, recommended amounts and juice or PAC conversions are not created. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Actual adherence, discontinuation, content, intake schedule and exposure distribution are unverified. - Required materials and conditions: Three-group plans, actual exposure, duration and adherence - Materials to obtain first: Actual adherence, discontinuation, content, intake schedule and exposure distribution are unverified. - Further research: Material needed: Actual adherence, discontinuation, content, intake schedule and exposure distribution are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Three-group plans, actual exposure, duration and adherence must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Three-group plans, actual exposure, duration and adherence with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N05 · Actual placebo comparison conditions Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The study was double-blind and placebo-controlled. The design label alone does not verify actual placebo ingredients, frequency, sensory matching or concurrent care. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Placebo specifications, exposure, appearance, taste, contact and matching of care are unverified. - Required materials and conditions: Placebo composition, exposure, sensory matching and concurrent care - Materials to obtain first: Placebo specifications, exposure, appearance, taste, contact and matching of care are unverified. - Further research: Material needed: Placebo specifications, exposure, appearance, taste, contact and matching of care are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Placebo composition, exposure, sensory matching and concurrent care must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Placebo composition, exposure, sensory matching and concurrent care with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N06 · Randomization and double-blinding procedures Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original design label is a three-arm double-blind randomized placebo-controlled trial. The label does not verify allocation concealment or masking of all assessors and analysts. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Sequence generation, concealment, masking targets and maintenance, and analyst involvement are unverified. - Required materials and conditions: Sequence, concealment, masking targets and maintenance, and analysis - Materials to obtain first: Sequence generation, concealment, masking targets and maintenance, and analyst involvement are unverified. - Further research: Material needed: Sequence generation, concealment, masking targets and maintenance, and analyst involvement are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Sequence, concealment, masking targets and maintenance, and analysis must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Sequence, concealment, masking targets and maintenance, and analysis with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N07 · The124 participants and group/outcome denominators Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The record of124 participants and three groups is preserved. Group counts, complete follow-up, completeness of IPSS analysis and equal allocation are not inferred. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Group allocation, completion, attrition, discontinuation, outcome-analysis counts and reasons are unverified. - Required materials and conditions: Allocation, completion, analysis and attrition - Materials to obtain first: Group allocation, completion, attrition, discontinuation, outcome-analysis counts and reasons are unverified. - Further research: Material needed: Group allocation, completion, attrition, discontinuation, outcome-analysis counts and reasons are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Allocation, completion, analysis and attrition must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Allocation, completion, analysis and attrition with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N08 · Definition of total IPSS assessment Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original endpoint is International Prostate Symptom Score (IPSS) at three and six months. A subjective symptom scale is not converted into objective flow, residual urine or prostate-size outcomes. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Total-score composition, assessment procedures, baseline distribution, scale language and missing responses are unverified. - Required materials and conditions: Scale, total and subscores, responses and time points - Materials to obtain first: Total-score composition, assessment procedures, baseline distribution, scale language and missing responses are unverified. - Further research: Material needed: Total-score composition, assessment procedures, baseline distribution, scale language and missing responses are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Scale, total and subscores, responses and time points must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Scale, total and subscores, responses and time points with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N09 · Six-month changes within each group Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: Six-month changes of−3.1 points (250mg),−4.1 points (500mg) and−1.5 points (placebo) are group-specific records. Each group's change is not itself converted into an effect versus placebo. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Group baseline and end values, change variance, exact analysis denominators and models are unverified. - Required materials and conditions: Changes, baseline, units and denominators for each dose and placebo - Materials to obtain first: Group baseline and end values, change variance, exact analysis denominators and models are unverified. - Further research: Material needed: Group baseline and end values, change variance, exact analysis denominators and models are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Changes, baseline, units and denominators for each dose and placebo must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Changes, baseline, units and denominators for each dose and placebo with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N10 · Original approximate differences versus placebo Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The parent text's approximate differences of−1.6 and−2.6 points versus placebo are preserved. These are historical approximate statements, not newly calculated values, exact adjusted effects or CIs. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact between-group models, adjustment, CIs, denominators and estimand definitions are unverified. - Required materials and conditions: Between-group estimands, adjustment, CIs and historical calculation - Materials to obtain first: Exact between-group models, adjustment, CIs, denominators and estimand definitions are unverified. - Further research: Material needed: Exact between-group models, adjustment, CIs, denominators and estimand definitions are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Between-group estimands, adjustment, CIs and historical calculation must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Between-group estimands, adjustment, CIs and historical calculation with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N11 · Dose-specific P values and comparison scope Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original comparison P values are approximately .05 for250mg and <.001 for500mg. Approximately .05 is not turned into an exact P value, within-group P value, between-dose test or prespecified success criterion. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact P values, tested contrasts, direction, multiplicity and adjusted models are unverified. - Required materials and conditions: Reported P values, exact contrasts, models and multiplicity - Materials to obtain first: Exact P values, tested contrasts, direction, multiplicity and adjusted models are unverified. - Further research: Material needed: Exact P values, tested contrasts, direction, multiplicity and adjusted models are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Reported P values, exact contrasts, models and multiplicity must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Reported P values, exact contrasts, models and multiplicity with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N12 · An apparent dose-response pattern Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The parent text describes an apparent dose-response IPSS pattern as a strength. Group changes of−3.1 and−4.1 points, or each placebo comparison, are not turned into a direct between-dose difference or proof of an optimal dose. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Direct between-dose contrasts, exposure adherence, CIs and prespecified models are unverified. - Required materials and conditions: Direct comparison of doses, adherence and models - Materials to obtain first: Direct between-dose contrasts, exposure adherence, CIs and prespecified models are unverified. - Further research: Material needed: Direct between-dose contrasts, exposure adherence, CIs and prespecified models are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Direct comparison of doses, adherence and models must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Direct comparison of doses, adherence and models with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N13 · Minimal important-difference numbers by source Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The text's patient-anchored threshold of approximately3.1–5.2 points and the supporting citation's approximately5.2 overall and3.2 for moderate symptoms are preserved separately.3.1 and3.2 are not arbitrarily harmonized or recalculated. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: The exact source and conditions for3.1 in the text, and correspondence to the supporting cohort's3.2, are unverified. - Required materials and conditions: Textual thresholds, supporting citation estimates, populations and units - Materials to obtain first: The exact source and conditions for3.1 in the text, and correspondence to the supporting cohort's3.2, are unverified. - Further research: Material needed: The exact source and conditions for3.1 in the text, and correspondence to the supporting cohort's3.2, are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Textual thresholds, supporting citation estimates, populations and units must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Textual thresholds, supporting citation estimates, populations and units with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N14 · Role of the Blanker observational cohort Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: Blanker2019 is a Dutch primary-care observational cohort for IPSS/OABQ minimal important differences and appears only in the citations. It is not treated as cranberry efficacy, an independent RCT or a repeat of the same124 participants. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Supporting-cohort n, baseline severity, anchors, estimation methods, CIs and correspondence to the trial population are unverified. - Required materials and conditions: MID estimation design, population, denominators and criteria - Materials to obtain first: Supporting-cohort n, baseline severity, anchors, estimation methods, CIs and correspondence to the trial population are unverified. - Further research: Material needed: Supporting-cohort n, baseline severity, anchors, estimation methods, CIs and correspondence to the trial population are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for MID estimation design, population, denominators and criteria must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects MID estimation design, population, denominators and criteria with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S02 ### N15 · Mean differences and individual importance thresholds Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The parent text states that approximately−1.6 and−2.6 points fell below estimated thresholds. This is not turned into no effect for every individual, treatment failure, a new grade or response rates. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact correspondence between group means and individually important changes, distributions and prespecified criteria is unverified. - Required materials and conditions: Estimands, individual versus group interpretation and relevance criteria - Materials to obtain first: Exact correspondence between group means and individually important changes, distributions and prespecified criteria is unverified. - Further research: Material needed: Exact correspondence between group means and individually important changes, distributions and prespecified criteria is unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Estimands, individual versus group interpretation and relevance criteria must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Estimands, individual versus group interpretation and relevance criteria with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N16 · IPSS subscores and quality of life Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The stored summary's quantitative result is six-month IPSS change. Separately linked item, subscore or quality-of-life results are not assumed. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Item, subscore and QoL definitions, time points, denominators, exact effects, CIs and hierarchy are unverified. - Required materials and conditions: Separate total, item, subscore and QoL outcomes - Materials to obtain first: Item, subscore and QoL definitions, time points, denominators, exact effects, CIs and hierarchy are unverified. - Further research: Material needed: Item, subscore and QoL definitions, time points, denominators, exact effects, CIs and hierarchy are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Separate total, item, subscore and QoL outcomes must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Separate total, item, subscore and QoL outcomes with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N17 · Three and six months, and persistence after completion Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The endpoint label includes three and six months, but current quantitative values concern six months. Three months is not treated as a separate replication trial or confirmation of identical numbers. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Three-month quantitative values, denominators, time-specific missingness and persistence beyond six months are not linked. - Required materials and conditions: Time-specific results, denominators and post-discontinuation persistence - Materials to obtain first: Three-month quantitative values, denominators, time-specific missingness and persistence beyond six months are not linked. - Further research: Material needed: Three-month quantitative values, denominators, time-specific missingness and persistence beyond six months are not linked. This records needed materials; no new research was executed. - Conditions for verification: Material for Time-specific results, denominators and post-discontinuation persistence must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Time-specific results, denominators and post-discontinuation persistence with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N18 · Prespecified IPSS statements and registration Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The parent text describes a prespecified IPSS endpoint, while the citation flags registration as unverified. Absence of a registration-identifier key in the evidence record is not turned into no registration or completed preregistration. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Original registration, recruitment and registration timing, protocol, SAP and amendment history are unread. - Required materials and conditions: Original prespecification statements, registration, protocol and SAP - Materials to obtain first: Original registration, recruitment and registration timing, protocol, SAP and amendment history are unread. - Further research: Material needed: Original registration, recruitment and registration timing, protocol, SAP and amendment history are unread. This records needed materials; no new research was executed. - Conditions for verification: Material for Original prespecification statements, registration, protocol and SAP must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Original prespecification statements, registration, protocol and SAP with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N19 · Plans for multiple doses, times and outcomes Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The two doses,3/6 months, IPSS and objective outcomes have distinct analysis scopes. A prespecified-IPSS statement is not extended into verified prespecified primary effects for all subscores or flow outcomes. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact hierarchy, dose/time contrasts, multiplicity and the complete SAP are unverified. - Required materials and conditions: Prespecified hierarchy, contrasts, multiplicity and analysis models - Materials to obtain first: Exact hierarchy, dose/time contrasts, multiplicity and the complete SAP are unverified. - Further research: Material needed: Exact hierarchy, dose/time contrasts, multiplicity and the complete SAP are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Prespecified hierarchy, contrasts, multiplicity and analysis models must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Prespecified hierarchy, contrasts, multiplicity and analysis models with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N20 · Blinding and measurement of symptoms Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: Double-blinding and placebo control are design strengths recorded in the original text. Actual masking maintenance and standardization of symptom responses and analyses are not thereby verified. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Masking maintenance, assessment procedures, missing responses, analysts and expectancy effects are unverified. - Required materials and conditions: Participants, assessors, scale administration and expectancy - Materials to obtain first: Masking maintenance, assessment procedures, missing responses, analysts and expectancy effects are unverified. - Further research: Material needed: Masking maintenance, assessment procedures, missing responses, analysts and expectancy effects are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Participants, assessors, scale administration and expectancy must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Participants, assessors, scale administration and expectancy with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N21 · Concurrent care and actual exposure Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: This is a comparison of three branded-powder groups. Identical or absent concurrent urinary-symptom care, medication, lifestyle changes and product adherence are not inferred. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Concurrent treatment, lifestyle changes, adherence, discontinuation and baseline adjustment are unverified. - Required materials and conditions: Medication, lifestyle, concurrent interventions and adherence - Materials to obtain first: Concurrent treatment, lifestyle changes, adherence, discontinuation and baseline adjustment are unverified. - Further research: Material needed: Concurrent treatment, lifestyle changes, adherence, discontinuation and baseline adjustment are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Medication, lifestyle, concurrent interventions and adherence must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Medication, lifestyle, concurrent interventions and adherence with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N22 · Analysis populations and missing-data handling Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original124 describes total participants; completion counts, missingness rates, ITT and PP are not provided. Parent scores and design labels do not fill the analysis scope. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Group attrition, missing IPSS, exclusions, ITT, PP, imputation and sensitivity analyses are unverified. - Required materials and conditions: ITT, PP, group attrition/discontinuation and missing outcomes - Materials to obtain first: Group attrition, missing IPSS, exclusions, ITT, PP, imputation and sensitivity analyses are unverified. - Further research: Material needed: Group attrition, missing IPSS, exclusions, ITT, PP, imputation and sensitivity analyses are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for ITT, PP, group attrition/discontinuation and missing outcomes must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects ITT, PP, group attrition/discontinuation and missing outcomes with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N23 · Within-group objective-flow and residual-urine comparisons Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original text says Qmax, Qavg and residual urine changed from baseline in the500mg group, without presenting a confirmed effect versus placebo. The placebo-controlled IPSS signal is not transferred into flow or residual-urine success. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Exact objective values, units, time points, denominators, between-group effects and CIs are unverified. - Required materials and conditions: IPSS versus Qmax, Qavg and residual urine; within/between-group distinctions - Materials to obtain first: Exact objective values, units, time points, denominators, between-group effects and CIs are unverified. - Further research: Material needed: Exact objective values, units, time points, denominators, between-group effects and CIs are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for IPSS versus Qmax, Qavg and residual urine; within/between-group distinctions must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects IPSS versus Qmax, Qavg and residual urine; within/between-group distinctions with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N24 · Scope of other clinical and product questions Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The parent text records that definitive prostate-size and urinary-flow claims exceed scope. The IPSS signal is not turned into prostate treatment, infection prevention, treatment replacement or efficacy of ordinary juice or other PAC products. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Direct evidence for other clinical outcomes, products, populations and treatment replacement is not linked. - Required materials and conditions: Direct measurement, comparisons and generalization - Materials to obtain first: Direct evidence for other clinical outcomes, products, populations and treatment replacement is not linked. - Further research: Material needed: Direct evidence for other clinical outcomes, products, populations and treatment replacement is not linked. This records needed materials; no new research was executed. - Conditions for verification: Material for Direct measurement, comparisons and generalization must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Direct measurement, comparisons and generalization with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N25 · One shared trial, supporting thresholds and independent replication Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The Vidlar2016 trial of124 participants, three groups and3/6 months is shared by two sheets. The Blanker MID cohort is not efficacy replication. Groups, times, supporting citations and the two sheets are not counted as unique trials or participant totals. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Separate efficacy replication with the same product, population and comparison, and actual independent-study relationships, are not linked. - Required materials and conditions: Efficacy reports, cohort roles and duplicate times/sheets - Materials to obtain first: Separate efficacy replication with the same product, population and comparison, and actual independent-study relationships, are not linked. - Further research: Material needed: Separate efficacy replication with the same product, population and comparison, and actual independent-study relationships, are not linked. This records needed materials; no new research was executed. - Conditions for verification: Material for Efficacy reports, cohort roles and duplicate times/sheets must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Efficacy reports, cohort roles and duplicate times/sheets with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N26 · Naturex employee authors, support and conflicts Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The original funding field records two Naturex-employed authors and a branded test product. Employment information is not turned into complete verification of funding, free product support or conflicts. Support for the Blanker cohort is separate. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Funding roles, product supply and free support, employee-author roles, conflicts and supporting-cohort support are unverified. - Required materials and conditions: Employment, product, funding, support and conflict disclosures - Materials to obtain first: Funding roles, product supply and free support, employee-author roles, conflicts and supporting-cohort support are unverified. - Further research: Material needed: Funding roles, product supply and free support, employee-author roles, conflicts and supporting-cohort support are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Employment, product, funding, support and conflict disclosures must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Employment, product, funding, support and conflict disclosures with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N27 · Laboratory changes and clinical safety Verification status: Unverified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: Parent safety is unknown; no clinical-chemistry or hematology change over six months is an original statement. It is not turned into zero adverse events, exclusion of rare harms or long-term safety. Interactions such as warfarin remain a possibility statement in the original text. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Event definitions, collection, group denominators, discontinuation, rare and long-term harms, and direct interaction evidence are unverified. - Required materials and conditions: Adverse events, hematology/clinical chemistry, exposure and denominators - Materials to obtain first: Event definitions, collection, group denominators, discontinuation, rare and long-term harms, and direct interaction evidence are unverified. - Further research: Material needed: Event definitions, collection, group denominators, discontinuation, rare and long-term harms, and direct interaction evidence are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Adverse events, hematology/clinical chemistry, exposure and denominators must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Adverse events, hematology/clinical chemistry, exposure and denominators with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01 ### N28 · Parent/subclaim values, languages and dates Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: Parent C46, B/P/R1/I0/E~/B1, unrecorded precision, four false flags, empty override reasons, and subclaim C/note are preserved. Original languages,2026-09-07, empty corrections array/deliberation string, and historical PubMed/effect/scoring checks are not inherited as current review or subclaim scores. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: Subclaim score, status and axes, new corrections and external details behind historical checks are unverified. - Required materials and conditions: Parent C46, subclaim C, axes, corrections and history - Materials to obtain first: Subclaim score, status and axes, new corrections and external details behind historical checks are unverified. - Further research: Material needed: Subclaim score, status and axes, new corrections and external details behind historical checks are unverified. This records needed materials; no new research was executed. - Conditions for verification: Material for Parent C46, subclaim C, axes, corrections and history must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Parent C46, subclaim C, axes, corrections and history with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ### N29 · Summary reading, source links and updates Verification status: Partly verified Reading scope: Stored summary read; external abstracts, full texts, registration, protocols and SAPs unread - Current findings: The efficacy summary and supporting citation's MID wording were used, retaining original paper links. External abstracts, full texts, registration, protocols, SAPs and conflict disclosures are unread and access was not attempted. External source links were not tested. - Why unverified: The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. - Reason for missing information: External original acquisition, reading, source-link verification and review of existing content remain incomplete. - Required materials and conditions: Efficacy/MID summaries versus unread external material - Materials to obtain first: External original acquisition, reading, source-link verification and review of existing content remain incomplete. - Further research: Material needed: External original acquisition, reading, source-link verification and review of existing content remain incomplete. This records needed materials; no new research was executed. - Conditions for verification: Material for Efficacy/MID summaries versus unread external material must be linked to the selected subclaim, parent context, original report, time points, comparator and denominators, distinguishing unread external material. - Why this condition is needed: This condition connects Efficacy/MID summaries versus unread external material with the selected question, actual population, test product, comparator, symptom scale, objective outcomes, time points, denominators and harms. - Application exceptions: Preserve original numbers while distinguishing total IPSS/subscores/QoL, objective flow/residual urine/prostate size, group changes/placebo contrasts/between-dose comparisons, MID sources and individual/group interpretation, timing, denominators, products, harms and unread external material. No new calculations, hypothetical examples, effects, CIs, regrading, independence certification, product intake, urinary/prostate treatment, prevention or treatment-replacement advice is created. - Remaining uncertainty: External original material is unread and review of existing content remains incomplete. Original grades, scores, axes, historical verification and independence statements are not treated as new verdicts or certification. - Referenced methods: Preserved C/E/H application conditions concerning questions, populations, interventions, comparators, reports versus studies, endpoints, denominators and harms were referenced. - Related sources: S01, S02 ## Evidence and sources ### S01 Vidlar A et al. 2016 [PubMed](https://pubmed.ncbi.nlm.nih.gov/26049866/) Materials actually read: Summary read; external material unread Findings recorded in the summary: Six-month changes−3.1 points (250mg),−4.1 points (500mg),−1.5 points (placebo) Record level: Original efficacy summary; group changes distinguished from placebo differences Independent replication: The Vidlar2016 Flowens trial of124 participants, three groups and3/6 months is shared by two sheets. Group IPSS changes, historical approximate placebo contrasts and objective-flow/residual-urine changes from baseline in the500mg group are distinguished. Blanker2019 is a supporting observational MID cohort, not cranberry efficacy replication. Textual3.1–5.2 and citation values5.2 overall/3.2 moderate are preserved separately. The same participants, groups, times, sheets and supporting citations are not newly added as unique trials or participant totals. Confirmed unique-trial, participant and independent-replication totals remain unrecorded. | Material | Public availability | Access status | Actually read | Notes | |---|---|---|---|---| | Stored summary | Stored file | Stored summary | Summary read | Only stored-summary and bibliographic content was used for production. External material verification/review is not complete. | | External paper | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Registration material | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Protocol | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Statistical analysis plan | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Funding, product-support and COI material | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | ### S02 Blanker MH, et al. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care. BMJ Open. 2019;9:e032795. PMID: 31874883. PMCID: PMC7008409. DOI: 10.1136/bmjopen-2019-032795. [PubMed](https://pubmed.ncbi.nlm.nih.gov/31874883/) Materials actually read: Summary read; external material unread Findings recorded in the summary: Patient-anchored IPSS minimal important differences were estimated at approximately5.2 points overall and3.2 for moderate symptoms. Record level: Observational-cohort MID citation summary; not an efficacy result Independent replication: The Vidlar2016 Flowens trial of124 participants, three groups and3/6 months is shared by two sheets. Group IPSS changes, historical approximate placebo contrasts and objective-flow/residual-urine changes from baseline in the500mg group are distinguished. Blanker2019 is a supporting observational MID cohort, not cranberry efficacy replication. Textual3.1–5.2 and citation values5.2 overall/3.2 moderate are preserved separately. The same participants, groups, times, sheets and supporting citations are not newly added as unique trials or participant totals. Confirmed unique-trial, participant and independent-replication totals remain unrecorded. | Material | Public availability | Access status | Actually read | Notes | |---|---|---|---|---| | Stored summary | Stored file | Stored summary | Summary read | Only stored-summary and bibliographic content was used for production. External material verification/review is not complete. | | External paper | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Registration material | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Protocol | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Statistical analysis plan | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | | Funding, product-support and COI material | Public availability unverified; only bibliography links preserved | Unread; access not attempted | Not read | No external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status. | ## Review criteria and methods These are Chamgap's own application conditions, informed by the relevant sections of official methodological guidance. They do not constitute official assessment-tool certification or a new efficacy score. - M03 [Cochrane Handbook 6.5 (2024), chapter updated 2023-08](https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-03) · §3.1, §3.2.1–3.2.3, MECIR C5/C7/C13 · Clearly record the question, eligibility conditions and reasons for changes, and distinguish variations in interventions. · Preserved method HTML copies; no current method-content re-review or official tool execution - M04 [Cochrane Handbook 6.5.1 (2025), chapter updated 2025-03](https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-04) · §4.5, §4.6.1–4.6.3, MECIR C42 · Distinguish studies from reports and link them; do not omit a study solely because results are unreported. · Preserved method HTML copies; no current method-content re-review or official tool execution - M08 [Cochrane Handbook 6.5 (2024), chapter updated 2019-10](https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-08) · §8.1–8.2.3, Table 8.2.a · Define the outcome and effect of interest, then examine randomization, deviations, missing data, measurement and selective reporting. · Preserved method HTML copies; no current method-content re-review or official tool execution - M15 [Cochrane Handbook 6.5 (2024), chapter updated 2023-08](https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-15) · §15.2.4, §15.3.1–15.3.3 · Distinguish effect estimates, intervals, importance and applicability. Sample size alone does not determine precision. · Preserved method HTML copies; no current method-content re-review or official tool execution - M19 [Cochrane Handbook 6.5 (2024), chapter updated 2019-10](https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-19) · §19.1.2, §19.2.1–19.2.4 · Harm questions may require different designs, populations and follow-up from efficacy questions. Case reports do not establish incidence rates. · Preserved method HTML copies; no current method-content re-review or official tool execution ## What the statuses mean - Met: Status for necessary evidence confirmed after existing content review. No completion is declared in the current presentation. - Partly verified: Some information in the stored summary is linked into the table. External comparison/content review is not complete. - Unverified: The article leaves this unverified, or required material is absent from the current stored summary. This is distinct from zero, absence or safety. - Review incomplete: Existing content review remains incomplete. - Not reported: Not reported within the stored material actually read; not extended to the entire primary paper. - Inaccessible: Means an actual access failure. Access not attempted here is not assigned this state. - Not applicable: Not used as a substitute for an evidence gap. - Conflicting data: Requires an observed disagreement under the same comparison criteria; not automatically judged in this production. - Insufficient evidence for the conditions: Marks a gap in additional material required by the selected conditions; not a new efficacy grade. ## Change history 2026-10-16 · Public page/materials 1.0. Public pages and materials were created from the existing 29 items. No new clinical search, verification-status change or scoring was performed.